Logistic regression for overall population. by Krystal Hunter (6820052)

Subjects:

BMISES_Data_Part1. by Krystal Hunter (6820052)

Subjects:

Baseline characteristics of HSES/LSES population. by Krystal Hunter (6820052)

Subjects:

Baseline characteristics of overall population. by Krystal Hunter (6820052)

Subjects:

Diagram of study population. by Krystal Hunter (6820052)

Subjects:

Definitions of the key terms used in this study. by Eriko Takahashi (22608061)

Subjects:

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

<i>CTSZ</i> SNPs significantly associated with TB severity in Ugandan household contact study cohorts, sorted by ascending <i>p</i>-value. by Rachel K. Meade (22216529)

Subjects:

Effects of compound 4f on neuroinflammation in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

Pharmacokinetics and pharmacodynamics of compound 4f in mice. by Naoto Arimura (416442)

Subjects:

Effects of cell culture patterns on injury and inflammation induced by the S1 protein. by Yanru Liu (1662463)

Subjects:

Effects of S1 protein and exposure duration on co-cultures of HPAEpics and AMs. by Yanru Liu (1662463)

Subjects:

Effects of compound 4f on cognitive function in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

Effects of compound 4f on the seizure-like response elicited by kainic acid (KA). by Naoto Arimura (416442)

Subjects:

The effects of cannabinoid receptor antagonists against neuroprotective effects of compound 4f in KA-treated mice. by Naoto Arimura (416442)

Subjects:

Effects of compound 4f on neuronal cell loss in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

DataSheet1_Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR... by Colton Ladbury (19768281)

Flow of participants through the study. by Sedighe Esmaeilzadeh (21100668)

“…Furthermore, melatonin significantly decreased sleep latency, exhibiting a large effect size, and contributed to a medium reduction in the use of sleep medications. …”

Demographic Characteristics of Participants. by Sedighe Esmaeilzadeh (21100668)

“…Furthermore, melatonin significantly decreased sleep latency, exhibiting a large effect size, and contributed to a medium reduction in the use of sleep medications. …”

Gene expression levels of <i>CB1R</i>, <i>CB2R</i>, and <i>MAGL</i> in KA-injected mice treated with compound 4f. by Naoto Arimura (416442)

Subjects: